Dr. Francisco A. Kerdel is the founder of Florida Academic Dermatology Centers. He is nationally and internationally renowned as one of the leaders in medical dermatology. Patients are referred to his practice from throughout the United States, Latin America and the Caribbean. Many of these patients are referred from other dermatologists in recognition of his clinical expertise and innovative approaches to treatment.
He attended the St. Thomas Hospital Medical School, London University, United Kingdom. Dr. Kerdel completed his dermatology residency at Harvard Medical School, Boston, MA where he was chief resident during the year 1983-1984. He completed Fellowships at Guy’s Hospital, London, England and New York University School of Medicine, New York, NY. He is Director of Dermatology Inpatient at The University of Miami Hospital, Miami, FL, and former Professor of Dermatology at the University of Miami.
Dr. Kerdel is the current Treasurer-General of the International Society of Dermatology and the Foundation for International Dermatologic Education. Other society memberships include the American Academy of Dermatology, Society for Investigative Dermatology, American Dermatological Association, Cuban, Broward, Miami and Florida Societies of Dermatology.
Dr. Kerdel has been chosen an Honorary Member of the Venezuelan, Argentinean and Chilean Societies of Dermatology and a corresponding member of the Venezuelan Academy of Medicine. Over 150 scientific articles, 33 books and book chapters and 20 abstracts have been authored by Dr. Kerdel.
As an invited speaker, Dr. Kerdel has spoken at national meetings and at international meetings worldwide. He has been a visiting professor in the United States, Japan, Portugal, Italy, Australia, Brazil, Chile, Spain, England, Venezuela, Colombia, Uruguay and Mexico.
Larkin Community Hospital Grand Rounds Cases
This lecture will provide attendees with a useful form of inpatient dermatology grand rounds implemented by Larkin Community Hospital.
- Discuss new inpatient dermatology unit descriptions
- Discuss new format for implementing grand rounds
- Provide interesting case discussions
- New advances in dermatologic treatment.
- New methods of diagnosis or treatment.
- Development of new technology.
- Advances in medical knowledge.
- Case studies seen at Grand Rounds.
Core Competencies: 2, 3, 4, 5, 6
Disclosures: Amgen, Galderma, Janssen Biotech, AbbVie, Pfizer, Novartis, Astrozeneca, Valeant, Celgene